Safety and Efficacy of NK520 to Treat Relapsed/Refractory Acute Myeloid Leukemia
Clinical trial NCT06541444 · RECRUITING
Trial details
- NCT number
- NCT06541444
- Sponsor
- Base Therapeutics (Shanghai) Co., Ltd.
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-01
- Primary completion
- 2026-06-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.